These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1533557)

  • 1. Vaccination against hepatitis B in preschool children with Down's syndrome.
    Vajro P; Lettera P; Fontanella A; Sbreglia C; Manzillo E; Sartorio R; Del Giudice E
    J Intellect Disabil Res; 1992 Feb; 36 ( Pt 1)():77-81. PubMed ID: 1533557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of a recombinant DNA hepatitis B vaccine in institutionalized patients with Down's syndrome.
    Van Damme P; Vranckx R; Meheus A
    Vaccine; 1990 Mar; 8 Suppl():S53-5; discussion S60-2. PubMed ID: 2139285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness and tolerance of genetically engineered vaccines for hepatitis B--a comparative study].
    Schmid K; Strebl H; Heck KJ; Weltle D; Raithel HJ
    Gesundheitswesen; 1992 May; 54(5):219-22. PubMed ID: 1535816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired response to recombinant hepatitis B vaccine in HIV-infected persons.
    Bruguera M; Cremades M; Salinas R; Costa J; Grau M; Sans J
    J Clin Gastroenterol; 1992 Jan; 14(1):27-30. PubMed ID: 1532609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of results of recombinant and plasma-derived hepatitis B vaccines in Japanese nursery-school children.
    Hayashi J; Kashiwagi S; Kajiyama W; Ikematsu H; Noguchi A; Nomura H; Ikeda K
    J Infect; 1988 Jul; 17(1):49-55. PubMed ID: 2974467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of an anti-hepatitis-B vaccination in a population at risk].
    Stellato M; Carbi S; Tosolini S
    Boll Ist Sieroter Milan; 1989; 68(1):34-41. PubMed ID: 2535244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response after intradermal administration of recombinant hepatitis B vaccine in children.
    Wiström J; Gustafsson A
    Scand J Infect Dis; 1990; 22(5):621-2. PubMed ID: 2148015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass vaccination against hepatitis B in preschool children: immunogenicity after three reduced doses.
    Milne A; Moyes CD; Waldon J; Pearce NE; Krugman S
    N Z Med J; 1989 Aug; 102(874):429-30. PubMed ID: 2527346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal immune response to hepatitis B vaccine in patients with Down's syndrome. A basis for immunization guidelines.
    Troisi CL; Heiberg DA; Hollinger FB
    JAMA; 1985 Dec; 254(22):3196-9. PubMed ID: 2933533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
    Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
    Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vaccination against hepatitis virus B infection. Vaccine from inactivated HBsAg positive plasma or recombinant vaccine?].
    Horejsí J
    Cas Lek Cesk; 1987 Jul; 126(31):981-2. PubMed ID: 2959363
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunogenicity of a combined hepatitis A and B vaccine in healthy young adults.
    Knöll A; Hottenträger B; Kainz J; Bretschneider B; Jilg W
    Vaccine; 2000 Apr; 18(19):2029-32. PubMed ID: 10706965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B vaccination in Down's syndrome and other mentally retarded patients.
    Heijtink RA; De Jong P; Schalm SW; Masurel N
    Hepatology; 1984; 4(4):611-4. PubMed ID: 6235163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response to hepatitis B vaccine in premature neonates.
    Chawareewong S; Jirapongsa A; Lokaphadhana K
    Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):39-40. PubMed ID: 1835140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis B at an open institution for the mentally retarded. Immunogenic effect of a recombinant anti-hepatitis-B vaccine].
    García O; Bruguera M; Mayor A; Sánchez-Tapias JM; Vall O; Rodés J
    Enferm Infecc Microbiol Clin; 1990 Mar; 8(3):148-52. PubMed ID: 2151250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intradermal hepatitis B virus vaccination for low- or non-responded health-care workers.
    Yasumura S; Shimizu Y; Yasuyama T; Hiroki O; Okada K; Tsukishiro T; Tsuchida T; Higuchi K; Watanabe A
    Acta Med Okayama; 1991 Dec; 45(6):457-9. PubMed ID: 1838229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Response to recombinant DNA antihepatitis B vaccine in mentally retarded patients with Down's syndrome. A controlled study].
    García Bengoechea M; Cortés A; Cabriada J; Albizu I; Dorronsoro M; Arriola JA; Arenas JI
    Med Clin (Barc); 1990 Apr; 94(14):528-30. PubMed ID: 2141377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Seroconversion following immunization with a plasma-derived vaccine against hepatitis B: study of a 3-injection protocol (0, 1, 6 months) in Brazzaville (Congo)].
    Taty-Taty R; Saliou P; Yala F; Couroucé AM; Arthaud ML; Nerelli B; Biendo M; Wassoumbou E
    Bull Soc Pathol Exot; 1990; 83(2):155-8. PubMed ID: 2145083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term follow-up study of HBsAb titers in subjects given HB vaccine and timing for additional vaccination].
    Nakao M; Yamada H; Ono T; Kuroki T; Kobayashi K; Yamamoto S; Monna T
    Nihon Shokakibyo Gakkai Zasshi; 1988 Jan; 85(1):20-7. PubMed ID: 2967388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.